Daniel Stuart Kapp

Daniel Stuart Kapp's AcademicInfluence.com Rankings

Daniel Stuart Kapp

Philosophy

#7277

World Rank

#10468

Historical Rank

Logic

#4331

World Rank

#5609

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Daniel Stuart Kapp's Degrees

Doctorate Medicine Stanford University

Why Is Daniel Stuart Kapp Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel Stuart Kapp's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers (2006) (562)
Therapeutic role of lymph node resection in endometrioid corpus cancer (2006) (385)
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. (2008) (361)
Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas (2008) (242)
Endometrial stromal sarcoma: a population-based analysis (2008) (220)
Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. (2008) (215)
Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. (2010) (182)
The outcomes of 27,063 women with unstaged endometrioid uterine cancer. (2007) (166)
Prognostic Factors for Uterine Cancer in Reproductive-Aged Women (2007) (155)
Ovarian cancer in younger vs older women: a population-based analysis (2006) (148)
Prognostic factors for high‐risk early‐stage epithelial ovarian cancer (2008) (147)
Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival. (1983) (145)
Stanford University institutional report. Phase I evaluation of equipment for hyperthermia treatment of cancer. (1988) (144)
Intensity‐modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal (2011) (138)
Radiotherapy after prostatectomy: is the evidence for dose escalation out there? (2008) (130)
Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques. (1992) (125)
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients (2007) (124)
Vulvar Melanoma: A Multivariable Analysis of 644 Patients (2007) (119)
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. (2010) (116)
Role of complete lymphadenectomy in endometrioid uterine cancer. (2007) (115)
Influence of the Gynecologic Oncologist on the Survival of Ovarian Cancer Patients (2007) (114)
National Institutes of Health Consensus Development Conference Statement on Cervical Cancer (1997) (114)
Radiation therapy of pineal region tumors: 25 new cases and a review of 208 previously reported cases. (1994) (112)
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—An analysis of 376 women (2007) (106)
Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. (1995) (104)
Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease. (1987) (102)
Cervical cancer. (2013) (102)
Important prognostic factors influencing outcome of combined radiation and hyperthermia. (1988) (101)
Oral cavity and oropharyngeal cancer in a younger population. Review of literature and experience at Yale (1985) (99)
Biological and Clinical Aspects of Hyperthermia in Cancer Therapy (1988) (98)
Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. (1990) (96)
Repair of Radiation-Induced Damage in Escherichia coli II. Effect of rec and uvr Mutations on Radiosensitivity, and Repair of X-Ray-Induced Single-Strand Breaks in Deoxyribonucleic Acid (1970) (94)
Epithelial carcinoma of the ovary: current strategies. (1981) (93)
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data. (1988) (93)
A computational model of radiolytic oxygen depletion during FLASH irradiation and its effect on the oxygen enhancement ratio (2019) (92)
Lymphadenectomy in endometrioid uterine cancer staging (2007) (88)
Influence of gynecologic oncologists on the survival of patients with endometrial cancer. (2011) (88)
Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States (2008) (86)
Body conformable 915 MHz microstrip array applicators for large surface area hyperthermia (1992) (84)
The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. (2006) (81)
Chemical nature of chain breaks produced in DNA by x-irradiation in vitro. (1970) (80)
Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients - a comparative analysis of total charges and complication rates. (2015) (80)
Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. (1997) (77)
Oral cavity and oropharyngeal cancer in a younger population. Review of literature and experience at Yale. (1985) (76)
Spiral microstrip hyperthermia applicators: technical design and clinical performance. (1990) (76)
Correlations of thermal washout rate, steady state temperatures, and tissue type in deep seated recurrent or metastatic tumors. (1987) (75)
The influence of conservative surgical practices for malignant ovarian germ cell tumors (2008) (74)
Angiosarcoma of the face and scalp. (1990) (72)
Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. (2000) (72)
Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. (1998) (71)
Glioblastoma multiforme: pathology, natural history and treatment. (1984) (71)
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. (2007) (71)
MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. (2014) (70)
Regional hyperthermia for advanced tumors: a clinical study of 353 patients. (1989) (68)
The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients (2007) (67)
Site and disease selection for hyperthermia clinical trials. (1986) (66)
Hyperthermia and radiation therapy of local-regional recurrent breast cancer: prognostic factors for response and local control of diffuse or nodular tumors. (1991) (66)
Uterine Neoplasms. Clinical Practice Guidelines in Oncology. (2009) (66)
Long‐term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma (1993) (65)
Characteristics of success in mentoring and research productivity - a case-control study of academic centers. (2012) (64)
Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. (2013) (64)
Stanford 3D hyperthermia treatment planning system. Technical review and clinical summary. (1993) (63)
Ependymomas of the spinal cord. (1983) (62)
Management of melanomas of the female genital tract (2008) (60)
External beam radiation therapy enhances local control in pigmented villonodular synovitis. (2009) (60)
Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies. (2007) (59)
Heating deep seated eccentrically located tumors with an annular phased array system: a comparative clinical study using two annular array operating configurations. (1987) (59)
RTOG quality assurance guidelines for interstitial hyperthermia. (1991) (58)
An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: costs, charges and reimbursements to hospitals and professionals. (2012) (58)
Correlation of thermal parameters with outcome in combined radiation therapy-hyperthermia trials. (1992) (57)
Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? (2008) (57)
Efficacy of adjuvant hyperthermia in the treatment of superficial recurrent breast cancer: confirmation and future directions. (1996) (56)
Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal (2013) (55)
Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. (2002) (55)
Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. (1994) (54)
Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. (2011) (54)
N3 (TNM-UICC) metastatic neck nodes managed by combined radiation therapy and hyperthermia: clinical results and analysis of treatment parameters. (1986) (54)
Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes (2019) (54)
Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. (2007) (54)
Anaplastic carcinoma following well-differentiated thyroid cancer: etiological considerations. (1982) (54)
Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. (2015) (53)
Adjuvant therapy in mixed mullerian tumors of the uterus. (1986) (53)
Hyperthermia in cancer therapy: current status (1990) (52)
Thermosensitization by sulfhydryl compounds of exponentially growing Chinese hamster cells. (1979) (51)
Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. (2010) (50)
Ultra-high dose rate FLASH irradiation may spare hypoxic stem cell niches in normal tissues. (2019) (50)
The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? (2008) (50)
High‐dose fraction radiation therapy for intracranial metastases of malignant melanoma: A comparison with low‐dose fraction therapy (1982) (48)
Thermoradiotherapy for residual microscopic cancer: elective or post-excisional hyperthermia and radiation therapy in the management of local-regional recurrent breast cancer. (1992) (48)
Hyperthermic oncology: current biology, physics and clinical results. (1989) (48)
Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy: the Harvard/Stanford experience. (1995) (48)
Hyperthermia and radiation therapy in the treatment of recurrent merkel cell tumors (1988) (47)
Therapeutic approaches to uterine papillary serous carcinoma: a preliminary report. (1987) (47)
RTOG quality assurance guidelines for clinical trials using hyperthermia for deep-seated malignancy. (1991) (46)
Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma. (1996) (45)
Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy. (2013) (44)
Principles of Hyperthermia (2000) (43)
Parameters predictive for complications of treatment with combined hyperthermia and radiation therapy. (1992) (43)
A comparison of thermal responses of human and rodent cells. (1989) (41)
Development and decay of systemic thermotolerance in rats. (1984) (41)
Prognostic factors and sites of failure in FIGO Stage I, Grade 3 endometrial carcinoma. (1987) (40)
The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer. (2013) (40)
Noninvasive microwave phased arrays for local hyperthermia: a review. (1990) (39)
Subsequent malignancies associated with carcinoma of the uterine cervix: including an analysis of the effect of patient and treatment parameters on incidence and sites of metachronous malignancies. (1982) (38)
The Value of Surgery for Retroperitoneal Sarcoma (2009) (37)
Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis. (2014) (36)
Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. (2005) (36)
Peripheral neuropathy and myonecrosis following hyperthermia and radiation therapy for recurrent prostatic cancer: correlation of damage with predicted SAR pattern. (1992) (36)
Increased skeletal metastases of spontaneous canine osteosarcoma after fractionated systemic hyperthermia and local X-irradiation. (1981) (36)
Histologic Variants of Cervical Involvement by Endometrial Carcinoma (1982) (36)
Radiation therapy for primary squamous cell carcinoma of the vagina: Stanford University experience. (1989) (34)
Glioblastoma multiforme: treatment by large dose fraction irradiation and metronidazole. (1982) (34)
Persistent and/or late complications of combined radiation therapy and hyperthermia. (1992) (34)
Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer (2013) (32)
Lack of in vitro repair of x-ray-induced chain breaks in DNA by the polynucleotide-joining enzyme. (1969) (32)
Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer. (1997) (32)
Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. (2008) (31)
Malignant granular cell tumor of the vulva in a 17-year-old: Case report and literature review. (2000) (30)
Combined modality therapy for advanced Hodgkin's disease: long-term followup data. (1982) (30)
Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US. (2018) (30)
Interstitial 192Ir flexible catheter radiofrequency hyperthermia treatments of head and neck and recurrent pelvic carcinomas. (1990) (30)
Incidental testicular irradiation from prostate IMRT: it all adds up. (2010) (29)
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale Experience. (1986) (29)
Clinical aspects of uterine papillary serous carcinoma (2008) (29)
Fallopian tube carcinoma. (1985) (29)
The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. (2006) (29)
Thermal tolerance to whole body hyperthermia. (1983) (29)
Production of systemic hyperthermia in the rat. (1984) (28)
Intense eosinophilic stromal infiltration in carcinoma of the uterine cervix: a clinicopathologic study of 14 cases. (1983) (28)
Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate. (1991) (27)
Seeing the invisible: direct visualization of therapeutic radiation beams using air scintillation. (2013) (26)
Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience. (1986) (26)
Cancer metastatic to the penis: treatment with hyperthermia and radiation therapy and review of the literature. (1992) (25)
Intraoperative radiation therapy in recurrent ovarian cancer. (2005) (25)
Regional Hyperthermia in Patients with Recurrent Genitourinary Cancer (1991) (25)
Anatomical site-specific modalities for hyperthermia. (1984) (24)
Is Cherenkov luminescence bright enough for photodynamic therapy? (2018) (24)
The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. (1999) (24)
An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer. (2012) (24)
Primary leiomyosarcoma of the vagina. A case report and literature review. (2000) (24)
Influence of water bolus temperature on measured skin surface and intradermal temperatures. (1994) (23)
Important Prognostic Factors Influencing Outcome of Combined Radiation and Hyperthermia (1989) (23)
Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas. (2014) (22)
Adenocarcinoma of the vagina arising in endometriosis: long-term survival following radiation therapy. (1982) (22)
The management of small-cell carcinomas of the gynecologic tract (2012) (22)
The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University (2019) (22)
Evolving trends in the initial locoregional management of male breast cancer. (2012) (21)
Does Omentectomy in Epithelial Ovarian Cancer Affect Survival? An Analysis of the Surveillance, Epidemiology, and End Results Database (2015) (21)
The omentum and omentectomy in epithelial ovarian cancer: a reappraisal. Part I--Omental function and history of omentectomy. (2013) (21)
Testicular dose from prostate cyberknife: a cautionary note. (2009) (21)
Axillary-subclavian vein thrombosis following combination chemotherapy and radiation therapy in lymphoma. (1986) (21)
Treatment selection for stage IIIA Hodgkin's disease patients. (1984) (21)
Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults. (2008) (21)
The centralization of robotic surgery in high-volume centers for endometrial cancer patients--a study of 6560 cases in the U.S. (2015) (20)
Mesonephric adenocarcinoma of the cervix: a case report and review of the literature. (2006) (20)
Disparities Associated With Inpatient Palliative Care Utilization by Patients With Metastatic Gynecologic Cancers: A Study of 3337 Women (2018) (20)
Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. (2008) (19)
Long term survivors with small cell carcinoma of the lung. (1981) (19)
Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 (2022) (18)
Cervical cancer: Clinical practice guidelines in oncology (2013) (18)
INSTERSTITIAL HYPERTHERMIA AND HIGH DOSE RATE BRACHYTHERAPY IN THE TREATMENT OF ANAL CANCER: A PHASE I/II STUDY (1994) (18)
Successful management of malignant pericardial effusion in metastatic squamous cell carcinoma of the uterine cervix. (1988) (17)
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients. (2015) (17)
The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials. (2016) (16)
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy. (2008) (16)
Direct clinical comparison of ultrasound and radiative electromagnetic hyperthermia applicators in the same tumours. (1995) (16)
External beam radiotherapy for synchronous rectal and prostatic tumors. (2001) (16)
A predictive assay for human tumor cellular response to hyperthermia using dansyl lysine staining and flow cytometry. (1988) (15)
New directions for radiation biology research in cancer of the uterine cervix. (1996) (15)
Adenoid cystic carcinoma of the salivary glands. Management of recurrent, advanced, or persistent disease with hyperthermia and radiation therapy (1990) (15)
Potential hazards of radiative electromagnetic hyperthermia in the presence of multiple metallic surgical clips. (1992) (14)
Orthovoltage Intraoperative Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer (2012) (14)
Toward a web-based real-time radiation treatment planning system in a cloud computing environment (2013) (14)
Uterine cancers: Clinical practice guidelines in oncology™ (2006) (13)
Reduction of pain and local complications when buffered lidocaine solution is used as a local anesthetic in conjunction with hyperthermia treatments: results of a randomized trial. (1992) (13)
Carcinoma of the cervical stump: comparison of radiation therapy factors, survival and patterns of failure with carcinoma of the intact uterus. (1983) (13)
Predictive assays for tumor response to single and multiple fractions of hyperthermia. (1988) (13)
Adjuvant Radiotherapy in Incompletely Staged IC and II Endometrioid Uterine Cancer (2007) (13)
Pure dysgerminoma of the ovary with elevated serum human chorionic gonadotropin: diagnostic and therapeutic considerations. (1985) (13)
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients. (2019) (12)
The chemical inhibition of the repair of single-strand breaks in DNA: post-irradiation sensitization to x-rays. (1971) (12)
The economic impact of surgical care for morbidly obese endometrial cancer patients: a nationwide study. (2016) (12)
Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study. (2021) (12)
Local hyperthermia and radiation therapy in the retreatment of superficially located recurrences in Hodgkin's disease. (1990) (12)
Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers. (2019) (11)
Metastatic gynecologic malignancies: advances in treatment and management (2018) (11)
The role of the radiation oncologist in the management of gynecologic cancer (1983) (11)
Stage IIIA carcinoma of the uterine cervix. (1986) (11)
What is the significance of nasal involvement in nasopharyngeal carcinoma? (1999) (11)
Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma. (2005) (10)
The influence of age and other prognostic factors associated with survival of ovarian immature teratoma - A study of 1307 patients. (2016) (10)
Radiation Therapy for Recurrent Clear-Cell Cancer of the Ovary (2016) (10)
Temperature elevation during brachytherapy for carcinoma of the uterine cervix: adverse effect on survival and enhancement of distant metastasis. (1984) (10)
Foreign- vs US-born Asians and the association of type I uterine cancer. (2015) (10)
Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study. (1994) (10)
Thermal dose response, systemic hyperthermia, and metastases: old friends revisited. (1996) (9)
Radiotherapy (second of two parts) (1983) (9)
Cervical cancer guidelines. Clinical practice guidelines in oncology. (2004) (9)
Prognostic factors in metastatic malignant melanoma treated with combined radiation therapy and hyperthermia. (1993) (9)
Deep Regional Hyperthermia of the Liver: A Clinical Study of 49 Patients (1989) (9)
Automated mechanical thermometry probe mapping systems for hyperthermia. (1992) (9)
Experience with Radiofrequency-Local Current Field Interstitial Hyperthermia: Biological Rationale, Equipment Development, and Clinical Results (1992) (9)
Ovarian cancer in younger vs older women: a population-based analysis (2007) (8)
Squamous carcinoma of the endometrium with ultrastructural observations and review of the literature. (1980) (8)
Automatic liver contouring for radiotherapy treatment planning (2015) (8)
Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer - is interval cytoreductive surgery still needed? (2020) (8)
Solid malignancies in individuals with Down syndrome: a case presentation and literature review. (2014) (8)
Breast cancer: chest wall hyperthermia-electron beam therapy. (1991) (8)
To treat pelvic nodes or not: could the greater testicular scatter dose from whole pelvic fields confound results of prostate cancer trials? (2009) (8)
From laboratory studies to clinical trials: past benefits and future directions in hyperthermia. (1994) (8)
Trends in the Utilization of Palliative Care in Patients With Gynecologic Cancer Who Subsequently Died During Hospitalization (2020) (8)
OSTEOGENIC SARCOMA OF THE NASAL CAVITY IN A CAT: POSTOPERATIVE CONTROL WITH HIGH DOSE‐PER‐FRACTION RADIATION THERAPY AND METRONIDAZOLE (1982) (8)
Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma (2010) (8)
Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary report. (1990) (8)
Radiotherapy (First of two parts) (1983) (8)
Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews. (2014) (7)
Hospital-acquired conditions after surgery for gynecologic cancer - An analysis of 82,304 patients. (2018) (7)
Cauda equina compression secondary to metastatic carcinoma of the uterine corpus: preservation of neurologic function and long-term survival following surgical decompression and radiation therapy. (1985) (7)
Temperature differentials between treatment and pretreatment temperatures correlate with local control following radiotherapy and hyperthermia. (1993) (6)
Treatment-pretreatment temperature differences correlate with local control (1992) (6)
Adjuvant radiation therapy in stage III node-positive uterine cancer. (2009) (6)
The increasing incidence of stage IV cervical cancer in the USA: what factors are related? (2022) (6)
Heterogeneity of heat response in murine, canine and human tumors: influence on predictive assays. (1991) (6)
Symptoms of Women With High-Risk Early-Stage Ovarian Cancer. (2022) (6)
Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. (2013) (6)
A Gene Expression Profile Test for the Differential Diagnosis of Ovarian Versus Endometrial Cancers (2011) (6)
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit. (2020) (6)
Analysis of temperature distributions of interstitial hyperthermia using a hot water system. (1993) (6)
Response to Dr. Oleson. (1992) (6)
Trends and survival outcomes of robotic, laparoscopic, and open surgery for stage II uterine cancer (2020) (6)
Uterine cancers. (2006) (6)
The microwave blanket: a large area conf0rmable applicator for hypertbermia of superficially located tumors (1989) (5)
Quality Assurance for Interstitial Radiofrequency-Induced Hyperthermia (1992) (5)
Income, inflammation and cancer mortality: a study of U.S. National Health and Nutrition Examination Survey mortality follow-up cohorts (2020) (5)
External beam irradiation combined with the use of 192-iridium implants and radiofrequency-induced hyperthermia in the treatment of prostatic carcinoma. (1991) (5)
Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer (2020) (5)
HYPERTHERMIA AND RADIATION THERAPY IN CANCER TREATMENT (1982) (5)
The association of serial ultrasounds and CA125 prior to diagnosis of ovarian cancer—Do they improve early detection? (2008) (5)
The use of cisplatinum for treatment of malignant glioma. (1982) (5)
Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study (2022) (5)
Subsequent Malignancies Associated With Carcinoma of the Uterine Cervix: Including an Analysis of the Effect of Patient and Treatment Parameters on Incidence and Sites of Metachronous Malignancies (1983) (5)
Abstract of ASTR scientific papers to be presentedPretreatment histopathological virulence factors in radiationtherapeutically managed carcinoma of the uterine cervix (1980) (5)
Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver disease. (2017) (5)
Does chemotherapy or radiation benefit surgical stage I uterine carcinosarcoma patients? (2019) (5)
HPV associated cancers in the United States over the last 15 years: Has screening or vaccination made any difference? (2021) (5)
Human Papillomavirus Vaccination Trends and Disparities in the United States: Who Is Getting Left Behind? (2021) (4)
Applying Artificial Intelligence to Gynecologic Oncology: A Review (2021) (4)
A cost effective strategy of bevacizumab in treatment of primary ovarian cancer — A subset analysis of ICON 7 trial (2012) (4)
A phase III study on hyperthermia in head and neck canine tumours: not hot enough. (1996) (4)
A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers – An analysis of GOG 218 (2012) (4)
Report of the NCI hyperthermia equipment evaluation contractors group (1987) (4)
Bladder cooling in patients treated with regional hyperthermia of the pelvis using an annular phased array. (1988) (4)
Getting real about NCI-designated Cancer Center advertising (2017) (4)
Cumulative minutes of isoeffective hyperthermia with T90=43°C is the treatment parameter most predictive for outcome in patients with metastatic adenocarcinoma of the breast and single tumor nodules per treatment field (1993) (4)
Clear Cell Ovarian Cancer: Optimum Management and Prognosis Remain Hazy. (2017) (3)
Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer. (2019) (3)
Acute bilobar collapse secondary to endobronchial metastatic seminoma. (1985) (3)
Metronidazole in conjunction with high dose fraction brain irradiation for glioblastoma multiforme: A preliminary report (1981) (3)
Immunosuppression by hypoxic cell radiosensitizers: a phenomenon of potential clinical importance. (1982) (3)
Invasive carcinoma of the uterine cervix: A comprehensive review of twenty years treatment experience at Yale University (1979) (3)
Normal-tissue effects of hyperthermia. (1989) (3)
THE ASSOCIATION OF OBESITY AND TYPE I UTERINE CANCER - IS THIS AN OVERSIMPLIFICATION? (2022) (3)
Subarachnoid spread of ependymoma: Diagnosis and evaluation of therapy by computerized tomography (1979) (3)
In Regard to Yoon et al. (2018) (3)
Relationship status and other demographic influences on survival in patients with ovarian cancer (2020) (3)
Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance. (2020) (3)
Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent (2011) (3)
Immediate Versus Delayed Hysterectomy for Endometrial Carcinoma: Surgical Morbidity and Hospital Stay (1985) (3)
Interstitial hyperthermia in head and neck oncology. (1990) (2)
The use of clinical characteristics to help prevent morcellation of leiomyosarcoma: An analysis of 491 cases. (2015) (2)
CASE REPORTS Adenocarcinoma of the Vagina Arising in Endometriosis: Long-Term Survival following Radiation Therapy (1982) (2)
36 Long term survival with whole abdominopelvic irradiation (WAI) in platinum-refractory ovarian cancer (1996) (2)
Factors associated with oophorectomy in children with benign ovarian masses (2017) (2)
Neuroendocrine cancer of the cervix: prognostic and predictive factors (2007) (2)
Prognosticfactorsincombinedhyperth ermia-radiationtherapy treatmentof local-regional recurrent breast cancer: an analysis of eight years of clinical experience (1990) (2)
Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes (2019) (2)
Upfront maintenance with anti-vascular versus PARP inhibitors in advanced ovarian cancer: A cost-effective analysis (2020) (2)
The increasing incidence of colorectal cancer in younger patients in the United States: Who, what, when, and where? (2020) (2)
Trends in utilization and cost of minimally invasive robotic surgery for endometrial cancer: A statewide analysis of 2296 patients (2011) (2)
147 Prognostic factors for survival and pelvic control in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy (1997) (2)
The effect of socioeconomic status on the survival of ovarian cancer patients (2008) (2)
Impact of mastectomy for breast cancer on spinal curvature: Considerations when treating patients with scoliosis (2020) (2)
Hyperthermia as an adjunct to radiation therapy in the treatment of superficially located malignancies: final results of a randomized trial of 2 vs. 6 hyperthermia treatments (1989) (2)
Neoadjuvant chemotherapy for advanced ovarian, fallopian tube and peritoneal cancer: An ancillary study of GOG 262 (2017) (2)
THE ROLE OF HYPERTHERMIA IN THE TREATMENT OF LOCAL-REGIONAL RECURRENCES OF BREAST CANCER: INFLUENCE OF PRETREATMENT AND TREATMENT FACTORS (1992) (2)
Progress toward a thermal dosimetry system? (1996) (2)
Intraoperative Radiation Therapy for Soft Tissue Sarcomas (2007) (1)
Applications for oncologic drugs — Lessons from the oncologic drug advisory committee (2012) (1)
Clinical indications for local-regional hyperthermia (HT) as an adjunct to radiation therapy (XRT) (1989) (1)
Disease stabilization versus response after bevacizumab treatment in recurrent ovarian cancer: How do we determine clinical efficacy? (2015) (1)
Comparison of depressive symptoms and inflammation between sexual minorities and heterosexuals using NHANES study of 8538 participants (2022) (1)
Is it more cost-effective to use bevacizumab in the primary treatment setting or at recurrence? An economic analysis (2011) (1)
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study. (2022) (1)
The treatment and survival differences of Asians vs. whites with epithelial ovarian cancer (2013) (1)
Cervical Cancer (2015) (1)
OBSERVATION VERSUS ADJUVANT TREATMENT IN EARLY STAGE UTERINE SEROUS CARCINOMA (2004) (1)
Local/regional hyperthermia of deep seated malignancies: A comparison of annular phased array microwave, focused ultrasound, and interstitial RF devices (1986) (1)
Abstracts of ASTRO scientific papers and posters to be presentedHyperthermia techniques for the management of local-regional recurrences from adenocarcinoma of the breast (1986) (1)
SU-D-BRD-01: Cloud-Based Radiation Treatment Planning: Performance Evaluation of Dose Calculation and Plan Optimization. (2014) (1)
An economic analysis: Examining the cost-effectiveness of bevacizumab and olaparib as upfront maintenance treatment of advanced ovarian cancer (2019) (1)
The significance of vimentin and other markers of tumor stromal microenvironment in response to intra-peritoneal chemotherapy (2011) (1)
Merkel cell carcinoma: demographic, clinical, and treatment parameters of prognostic significance (2016) (1)
Regional hyperthermia of the liver. (1989) (1)
The characterization of morbidly obese ovarian cancer patients in the United States: a study of demographic and socioeconomic status (2014) (1)
Comparison of clear cell ovarian cancer in Asian versus Caucasians: A NRG/GOG study. (2015) (1)
The increase in early detection and associated improved survival of cervical cancer in the US: A ten-year study of 6414 patients (2015) (1)
Outlook of the future landscape of artificial intelligence in medicine and new challenges (2021) (1)
The use of molecular markers to predict for optimal cytoreduction in ovarian cancer (2011) (1)
Esophago-pulmonary toxicity from concomitant use of adriamycin and irradiation. (1981) (1)
Chemotherapy response and survival in serous ovarian cancer patients with BRCA mutations (2011) (1)
Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Receiving Pelvic IMRT and Concurrent Chemotherapy (2012) (1)
Oncology and public health (2012) (1)
The impact of lymphadenectomy in women with endometrioid uterine cancer: A study of 39,396 women. (2006) (1)
The role of surgical staging in grade 1 endometrioid corpus cancer. (2006) (1)
Relative importance of diet and physical activity in cancer survival: An analysis of the US national health and nutrition examination survey (2019) (1)
Immunoregulatory gene expression and response to bevacizumab in ovarian cancer — An analysis of the cancer genome atlas (2012) (1)
Progress and trends in the utilization and adoption of palliative care in patients with terminal gynecologic cancer in the United States: A study of 4,264 women. (2019) (1)
Pretreatment temperatures of superficially-located tumors (1991) (1)
Opportunistic salpingectomy to decrease the risk of ovarian and tubal cancer during cesarean birth: Frequency, costs and complications--a study of 341 women (2017) (1)
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis (2022) (1)
Publication of oral and video presentations from the Society of Gynecologic Oncology annual meeting over 11 years – What characteristics were important? (2020) (1)
P10 02 SP – PRECLINICAL EVALUATION OF SEGMENTED INTERSTITIAL RADIOFREQUENCY (RF) ELECTRODES (1991) (1)
P41 08 TP – CORRELATION OF THERMAL PARAMETERS WITH OUTCOME IN HYPERTHERMIA (HT) TREATMENT (1991) (1)
Primary Squamous Cell Carcinoma of the Vagina: Prognostic Factors, Treatment Patterns, and Outcomes (2012) (1)
Socioeconomic disparities in inflammatory response on cancer mortality using national health and nutrition examination survey. (2018) (1)
The Healthcare Journey of Women With Advanced Gynecological Cancer From Diagnosis Through Terminal Illness: Qualitative Analysis of Progress Note Data (2021) (1)
MicroRNA as a novel predictor of response to bevacizumab in recurrent serous ovarian cancer: An analysis of The Cancer Genome Atlas (2011) (1)
Increased Urinary Cadmium Levels in Foreign-Born Asian Women—An NHANES Study of 9639 U.S. Participants (2022) (1)
THERMOTOLERANCE IN HUMAN SUBJECTS: CLINICAL SIGNIFICANCE AND METHODS OF DETERMINATION (1992) (1)
Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse. (2022) (1)
16 – Intraoperative Radiation Therapy (2010) (1)
Biomarker and in Vitro Chemoresistance Profiles of Undifferentiated Ovarian Cancers (2007) (1)
Differential microRNA expression in cis-platinum-resistant versus -sensitive ovarian cancer cell lines (2011) (1)
1060 Locally advanced prostatc cancer: Experience with combined pelvic external beam irradiation and interstitial thermobrachytherapy (1995) (1)
Gynecologic oncology: cancer update (first of two parts). (1980) (1)
Progress and Trends for Cancer Drug Approval – an Analysis of FDA Advisory Committee (2012) (1)
Corrigendum: A computational model of radiolytic oxygen depletion during FLASH irradiation and its effect on the oxygen enhancement ratio (2019 Phys. Med. Biol. 64 185005) (2020) (1)
Progress and trends in publication of oral and video presentations at the society of gynecologic oncology annual meeting from 2006 to 2016 (2021) (0)
Clinical applications of hyperthermia: Local-regional hyperthermia as adjunct to radiation therapy (1986) (0)
Trends in the pathological diagnosis of serous fallopian tube, peritoneal, and ovarian cancer in the US (2014) (0)
EP021/#1089 Trends in the incidence of invasive breast cancers in the Republic of China (2022) (0)
The increase in hospital charges associated with ovarian cancer treatment: An economic analysis of 83,552 patients (2015) (0)
Surgical stage IA clear cell ovarian cancer: Is adjuvant chemotherapy necessary? (2019) (0)
Higher obesity and lower screening rates in Hispanic women and associated increased breast cancer in the United States. (2022) (0)
Human papillomavirus-associated cancers in Taiwan over the last 18 years: The potential impact of screening, vaccination, and smoking. (2022) (0)
Sex cord stromal and germ cell ovarian cancer: Is there a racial disparity? (2020) (0)
Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults (2021) (0)
Disparities in the use of robotic surgery in endometrial cancer based on race and socioeconomic status in the United States (2014) (0)
Cervical cancer trends in Hispanic subgroups: who is most at risk? (2021) (0)
SU-E-T-622: Identification and Improvement of Patients Eligible for Dose Escalation with Matched Plans. (2014) (0)
Germline versus Somatic BRCA mutations: Analysis of the cancer genome atlas project in patients with advanced stage serous epithelial ovarian cancer (2012) (0)
Genomic expression of stem cell markers in association with recurrent epithelial ovarian cancer (2012) (0)
Adjuvant radiation therapy in women with stage III node-positive uterine cancer (2008) (0)
EP229/#754 Long-term survival among patients with various histologic subtypes of advanced ovarian cancer enrolled in NCI clinical trials (2022) (0)
Disparities in gynecologic oncologist care in patients with endometrial cancer in the United States (2011) (0)
Increase in postmenopausal women with distant stage breast cancer in the United States over the last 18 years: Who is the most at risk? (2022) (0)
Factors Associated with Successful FDA Approval After a Positive Phase III Clinical Trial Using Targeted Anticancer Agents (Poster) (2010) (0)
The increasing rate of metastatic vulvar cancer in the United States: what factors are responsible? (2021) (0)
Characteristics and outcomes of pharmaceutical versus nonpharmaceutical affiliated phase III clinical trials on targeted agents for cancer therapy. (2010) (0)
EP156/#955 Variability in high risk endometrial cancer risk in native versus us asians – a population analysis of US and Asia (2022) (0)
Thermal analysis of interstitial hyperthermic brachytherapy for prostate cancer (1992) (0)
The Role of Diet Compared to Physical Activity on Women's Cancer Mortality: Results From the Third National Health and Nutrition Examination Survey (2022) (0)
Factors associated with publication of plenary presentations at the Annual Meeting of the Society of Gynecologic Oncology (2008) (0)
Progress and trends in successful phase II clinical trials in advanced solid cancers over the past 20 years (2008) (0)
00075 PROGNOSTIC FACTORS IN VULVAR CANCER PATIENTS: A LARGE POPULATION-BASED STUDY (2005) (0)
Racial disparities in presentation and survival of ovarian yolk sac cancer patients: a study of 423 women. (2016) (0)
Young patients with cancer related to modifiable behaviors in the United States: What can we learn from them? (2021) (0)
Treatment of elderly women with epithelial ovarian cancer: Is chemotherapy alone appropriate? (2018) (0)
Trends of cancer associated with modifiable behavior in the U.S.: Is there a difference based on age, gender, or race? (2021) (0)
Racial disparities in the incidence of vulvar cancer in the United States: a study of 75,767 over 16 years (2021) (0)
FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10 years (2013) (0)
First Demonstration of Medical Radiation Treatment Beam Monitoring via Air Scintillation Imaging (2014) (0)
Professional Charges and Actual Reimbursements for Robotic vs. Laparoscopic Surgical Staging of Endometrial Cancer (2011) (0)
INCIDENTALTESTICULAR IRRADIATION FROM PROSTATE IMRT: ITALL ADDS UP (2010) (0)
Invasive extramammary Paget's disease of the vulva: incidence, trends and outcomes (2021) (0)
Surgical stage 1 mucinous ovarian cancer: Does chemotherapy impact survival? (2019) (0)
Seroprevalence of HPV Infections in the Cervix and Penis in Unvaccinated Individuals (2020) (0)
The trends and factors associated with ovarian preservation in women in the United States: A nationwide study of 469,517 women (2017) (0)
Trends in FDA approval of oncology drugs: Have we made progress? (2015) (0)
Suicide among gynecologic cancer patients: What are the associated risk factors? (2020) (0)
Social isolation, inflammation, and cancer mortality from the National Health and Nutrition Examination Survey - a study of 3,360 women (2021) (0)
The overall decrease in incidence of ovarian cancer in the United States: is this reflected in our racial ethnic groups? (2021) (0)
The pattern of CA-125 normalization during chemotherapy predicts for recurrence and survival in patients with high-risk early-stage ovarian cancer: A gynecologic oncology group study (2010) (0)
VMAT Treatment Planning Using Cloud Computing (2014) (0)
P31 16 WP – REDUCTION OF PAIN AND LOCAL COMPLICATIONS WHEN BUFFERED XYLOCAINE SOLUTION WAS USED AS A LOCAL ANESTHETIC IN CONJUNCTION WITH HYPERTHERMIA TREATMENTS: RESULTS OF A RANDOMIZED TRIAL (1991) (0)
Trends in modifiable behaviorally related cancers: Who is affected the most? (2021) (0)
Overall survival in early stage cervical cancer in the United States has improved over the last ten years (2013) (0)
Age and racial differences in the presentation of gestational trophoblastic neoplasia (2020) (0)
Trends and progress in phase III clinical trials on targeted agents in advanced cancers. (2010) (0)
Alarming trends in high-risk uterine cancer histologies in Black women in the US: Is obesity responsible? (138) (2022) (0)
Human Papillomavirus Vaccination Over Time in Heterosexual and Sexual Minority Adults in the United States (2022) (0)
Characteristics of patients with neuroendocrine tumors in the United States: A study of 392,412 patients. (2022) (0)
The economic impact associated with caring for the morbidly obese with endometrial cancer: A nationwide study of 6560 women (2014) (0)
1052 : Prognostic Factors for Outcomes and Complications for Primary Squamous Cell Carcinoma of the Vagina Treated With Radiation (2006) (0)
HPV infection rates for men vs. women: Additional screening is needed (446) (2022) (0)
A gene expression profile test that distinguishes ovarian from endometrial cancers. (2012) (0)
Ovarian cancer in younger vs older women: a population-based analysis (2007) (0)
Older patients with germ cell cancer of the ovary (2008) (0)
A clinical calculator to personalize chemotherapy in early-stage clear cell ovarian cancer (2021) (0)
Differentiating ovarian cancer stage, histology, and associated prognosis using pretreatment CA125: A study of4,555 patients (456) (2022) (0)
The disproportionate burden of cancer associated with social behaviors in young women in the United States. (2022) (0)
Types of surgery for morbidly obese endometrial cancer patients in the US: How and where do we make the largest impact? (2015) (0)
Clinical experience with BSD-1000 in the treatment of advanced deep seated tumors. (1989) (0)
Differences in BMI and physical activity in Whites versus Asians in California in association with type I uterine cancer (2015) (0)
The therapeutic benefit of extensive lymphadenectomy in advanced stage ovarian cancer. (2006) (0)
Feasibility of international trials of rare epithelial ovarian cancers based on trends in the United States and Asia (163) (2022) (0)
Foreign vs. U.S. born patients and the association of type I uterine cancer (2013) (0)
Trends in Incidence of Cancers Associated With Obesity and Other Modifiable Risk Factors Among Women, 2001-2018. (2023) (0)
Monte Carlo dose calculation for intracavitary brachytherapy (2000) (0)
The increase in type I uterine cancer in 9217 Hispanic women: A 20-year study (2014) (0)
Genetic control and chemical inhibition of the repair of radiation damage to bacterial DNA (1973) (0)
The association of VEGF A, B, and C expression in the survival of serous ovarian cancer patients (2011) (0)
The risk of less extensive surgical staging in endometrial cancer (2008) (0)
EP118/#744 Progress in uterine cancer survival in the United States from 2004–2016: who was left behind? (2022) (0)
The increasing incidence of uterine serous cancers in the elderly and Black women: what molecular markers can guide novel treatment approaches for these patients? (2021) (0)
P6 Cancers in minority women in the United States: What modifiable behaviors are most responsible? (2022) (0)
Disparities in the use of minimally invasive surgery in endometrial cancer based on race and SES in the US (2013) (0)
A Comparative Study of Minimally Invasive Versus Open Hysterectomy for Women With Fibroid Uterus - A Nationwide Study of 65,216 Patients. (2015) (0)
EP358/#948 Evaluating the racial/ethnic representation of targeted therapy clinical trials in gynecologic oncology: who is being left behind? (2022) (0)
Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis (2023) (0)
EP169/#289 Trends in uterine cancer mortality in United States: a 50-year population-based analysis (2022) (0)
Timing of initiation of chemotherapy after primary surgery for women with epithelial ovarian cancer: Does it matter? (2018) (0)
The role of extensive lymphadenectomy in stage I ovarian cancer. (2006) (0)
CA-125 and other prognostic factors associated with survival in stage I epithelial ovarian cancer: a study of 15,882 patients (2021) (0)
Local-regional hyperthermia as an adjunct to radiation therapy: Clinical indications and site-specific results (1990) (0)
In response to Thrall et al.: Hindsight is always perfect: Thermal-dose response, systemic hyperthermia, and metastases: Old friends revisited (1996) (0)
A test of the correlation of initial response with several parameterizations of equivalent minutes at 43°C in combined radiation therapy-hyperthermia trials (1993) (0)
P206 Factors associated with survival differences in immigrant Asians versus USA-born Asians with uterine cancer (2014) (0)
The impact of chemotherapy on the survival of early-stage I–II epithelial ovarian cancer (2008) (0)
Differences in survival between clear cell uterine and ovarian carcinoma patients (2015) (0)
Does performance of omentectomy in epithelial ovarian cancer affect survival? An analysis of the SEER database (2015) (0)
Development and decay of systemic thermotolerance in rats. (1989) (0)
Geographic trends in rare uterine sarcomas: could environment affect incidence? (403) (2022) (0)
Adjusted Dose and the Relation to Radiation-Induced Liver Disease During Liver 3-Dimensional Conformal Radiation Therapy (2016) (0)
The rate of germ cell and sex cord stromal ovarian cancer is increasing at different rates in the US and in Asia: Why? (185) (2022) (0)
Uterine cancer histology and stage at presentation in black and white women: A cohort study of 488,000 patients. (2020) (0)
Clinical nomogram to predict for para-aortic lymph node metastasis in advanced-stage endometrial cancer patients (2013) (0)
Immune biomarkers predictive of survival in epithelial ovarian cancer (2012) (0)
Stage I ovarian immature teratomas: Is there a role for chemotherapy? (2017) (0)
A clinical calculator to personalize chemotherapy in early-stage high risk epithelial ovarian cancer (2021) (0)
1009 Low rate of significant morbidity following treatment of patients with inoperable carcinoma of the cervix with external beam radiation and high-dose rate brachytherapy (1995) (0)
Obesity-related cancers disproportionately affect women compared to men in the United States (399) (2022) (0)
The effect of COVID‐19 on telehealth: Next steps in a post‐pandemic life (2022) (0)
Delayed recurrences and survival after relapse in patients initially treated with intraperitoneal chemotherapy for advanced ovarian cancer: A Gynecologic Oncology Group study. (2015) (0)
P205 Type I uterine cancer in US-born Asians versus immigrant Asians (2014) (0)
77 Sex cord stromal and germ cell ovarian cancer – is there a racial disparity? (2020) (0)
Adjuvant chemotherapy and radiation improve survival of surgical stage I uterine clear cell carcinoma patients (2019) (0)
The high rate of oophorectomy in children with ovarian masses in the United States: What factors are responsible? (2017) (0)
The rising rates of uterine cancer in Hispanic women of reproductive age in the United States (444) (2022) (0)
Ovarian cancer. (1982) (0)
Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer (2012) (0)
The increasing incidence of alcohol-related cancers in young adults in the United States: Who is most at risk? (2022) (0)
Improved outcomes of younger compared to older ovarian cancer patients — What is the role of immune regulation? (2012) (0)
Increased Skeletal MÃ©tastasesof Spontaneous Canine Osteosarcoma after Fractionated Systemic Hyperthermia and Local X-lrradiation1 (2006) (0)
Trends and progress of oncology drug development — An analysis of the FDA oncologic drug advisory committee reviews (2012) (0)
Disparities in HPV vaccination in young vs. older Hispanic adults and genital HPV prevalence (378) (2022) (0)
Quality assurance in clinical hyperthermia (1992) (0)
Metastatic gynecologic malignancies: advances in treatment and management (2018) (0)
The role of chemotherapy and radiation in AJCC surgical stage I uterine papillary serous carcinoma: A retrospective analysis of 4,970 patients (2019) (0)
Factors associated with the decreasing rate of oropharyngeal cancer in young adults in the United States. (2022) (0)
Advanced stage cervical cancer: Who is at risk and is it related to screening and vaccination practices? (441) (2022) (0)
Anatomical Site-specific Modalities for Hyperthermia1 (2006) (0)
Does chemotherapy or radiation benefit surgical stage I uterine carcinosarcoma patients? An analysis of 3,447 patients (2019) (0)
S12 02 MA – THE ROLE OF HYPERTHERMIA (HT) IN THE TREATMENT OF LOCAL-REGIONAL (LR) RECURRENCES OF BREAST CANCER: INFLUENCE OF PRETREATMENT AND TREATMENT PARAMETERS (1991) (0)
S30 01 TA – THERMOTOLERANCE IN HUMAN SUBJECTS: CLINICAL SIGNIFICANCE AND METHODS OF DETERMINATION (1991) (0)
The Oversimplification of Uterine Cancer Classifications and Risk Factors. (2022) (0)
Predictors for Success in a Phase III Trial—an Analysis of 315 Phase II Chemotherapy Trials for Advanced Cancers (2007) (0)
Racial and regional disparities and outcomes of stage II endometrial cancer patients after robotic surgery (2019) (0)
Poster — Thur Eve — 75: Patient‐specific Dose Escalation Using Patient‐Matching Machine Learning (2014) (0)
Serous tubal vs. ovarian vs. peritoneal vs. uterine cancers - A study of 12,369 women (2013) (0)
The increasing incidence of uterine cancer in the United States: Who is at greatest risk? (2018) (0)
P31 10 WP – HYPERTHERMIA AND RADIATION THERAPY IN THE TREATMENT OF CANCER METASTATIC TO THE PENIS (1991) (0)
EP200/#1081 Increasing incidence of sex cord stromal ovarian cancers in black women in the United States (2022) (0)
307 Hyperthermia: Progress in selection of treatment sites and thermal dose descriptors for the adjuvant use of local-regional hyperthermia in cancer therapy (1995) (0)
SU-E-J-131: Augmenting Atlas-Based Segmentation by Incorporating Image Features Proximal to the Atlas Contours (2015) (0)
O013/#813 Trends of metastatic leiomyosarcoma following the us food and drug administration (FDA) warning on laparoscopic power morcellators (2022) (0)
Germline vs. somatic BRCA mutations and response to chemotherapy and outcomes in serous ovarian cancer (2011) (0)
Characteristics of a phase II study that predict for a positive phase III trial—A study of 383 clinical trials (2007) (0)
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461 (2023) (0)
310 Hyperthermia: Rational and clinical applications (1996) (0)
The increasing incidence of granulosa cell tumors in the United States: what factors are responsible? (2021) (0)
BRCA mutations and advanced stage serous epithelial ovarian cancer—Does the type of mutation matter? (2012) (0)
The use of a geographic information system to identify advanced cervical cancer patients in California (2014) (0)
SU-E-J-131: Augmenting Atlas-Based Segmentation by Incorporating Image Features Proximal to the Atlas Contours (2015) (0)
Trends in uterine cancer incidence in the United States and Asian countries: A population analysis of 576,558 of women (2018) (0)
0743: The Number of Positive Lymph Nodes Portends for a Poorer Prognosis in Women with Stage Iiic-Iv Endometrioid Corpus Cancer (2006) (0)
SU-E-J-130: Automating Liver Segmentation Via Combined Global and Local Optimization (2015) (0)
Disparities in the survival trends in epithelial ovarian cancer patients in the United States (2018) (0)
33/#939 Trends in phase 3 clinical trials in ovarian cancer from 2001–2021 (2022) (0)
0554: Malignant Melanoma of the Vagina - Analysis of Prognostic Factors (2006) (0)
Dedication of the special issue of the International Journal of Hyperthermia honouring the retirement of George M. Hahn PhD (1994) (0)
Sexual orientation is irrelevant in HPV screening: Infection rates in heterosexual vs. lesbian/bisexual women (135) (2022) (0)
The effect of gynecologic oncologists on the survival of endometrial cancer patients (2008) (0)
AIAF+GEAREACONFDRMABIEAPPLXATORFDR~OF SUPERFIcIALLYLcxCATEDTUmRS (1989) (0)
Intraoperative Radiation Therapy in Recurrent Ovarian Cancer: P018 (2003) (0)
Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer. (2019) (0)
Racial disparities in prevalence of homologous recombination deficiency in ovarian, uterine, and cervical cancer tumors (2021) (0)
0555: Populaton-Based Analysis of Prognostic Factors in Vulvar Cancer (2006) (0)
0545: Trends in Surgical Treatment of Women with Invasive Cervical Cancers (2006) (0)
Quick Radiation Treatment Prostate Planning Using Matched-Plans: Improved Quality and Workflow (2014) (0)
0740: Increased Death Rate of Women Diagnosed with Uterine Corpus Cancer - What Factors Are Responsible? (2006) (0)
Association of cervical intraepithelial neoplasia 2 and 3 regression by human papilloma Virus Serotype (2012) (0)
EP369/#547 Clinical trial directed treatment and outcomes of black vs. whites with stage III ovarian cancer – an ancillary database study (2022) (0)
Trends in robotic surgery in uterine cancer: A nationwide study of 13,719 patients (2014) (0)
The increasing incidence of uterine cancers in younger women (2021) (0)
2124 Significance of localized miliary subdiaphragmatic seeding and size of initial postsurgical residual in patients with epithelial ovarian cancer (1997) (0)
Hospital characteristics associated with the utilization of robotic surgery in endometrial cancer (2013) (0)
Abandoning the HPV vaccine in Japan due to safety concerns - where is the evidence? (2019) (0)
P31 09 WP – PERSISTENT AND LATE COMPLICATIONS OF COMBINED HYPERTHERMIA AND RADIATION THERAPY (1991) (0)
Differences in presentation and survival of Asians versus Caucasians with ovarian cancer: A Gynecologic Oncology Group ancillary study of 7914 patients (2015) (0)
The rising incidence of sex cord stromal ovarian tumors in the US: Who is most at risk? (442) (2022) (0)
The potential role of immune regulation in the presentation of early vs. advanced ovarian cancer (2012) (0)
Differences in survival between Caucasians and Asians. (2018) (0)
Survival Outcome of Recurrent Early-Stage Ovarian Cancer Patients—What Factors are Important? (2007) (0)
The Prognostic Factors Responsible for Survival of Women with Neuroendocrine Small-Cell Cervical Carcinoma—A Study of 188 Women (2007) (0)
Improved survival of asians versus caucasians with ovarian cancer — What factors are responsible? (2013) (0)
Significance of Indeterminate Pulmonary Nodules Identified on Chest Computed-tomography in Adult Patients with Newly Diagnosed Sarcoma (2011) (0)
Differences in tumor immune regulation between African–American and Caucasian ovarian cancer patients (2012) (0)
The use of electronic health record-based tools to improve cervical cancer screening compliance in a large community-based health care organization (2015) (0)
Type I uterine cancer in United States (US)-born vs immigrants: A study of 4834 patients (2014) (0)
Successful management of malignant pericardial effusion in metastatic squamous cell carcinoma of the uterine cervix (1989) (0)
Radiation for Localized Ovarian Cancer Shows Benefits of Dose Escalation and for Treating Lymph Node Regions (2015) (0)
The association of relative survival benefit and approval of oncological drugs: An analysis of oncology drug advisory committee reviews. (2015) (0)
The significant of clinico-pathologic prognostic factors in malignant mixed mullerian uterine cancers (2008) (0)
Human papillomavirus vaccination in heterosexual and sexual minority individuals in the United States (2020) (0)
Correlation between type I uterine cancer and diet and lifestyle in US-born versus immigrant Asian subgroups (2015) (0)
The role of radiation therapy in the treatment of anal carcinoma: Techniques and current recommendations (1994) (0)
Gynecologic oncology: cancer update (second of two parts). (1980) (0)
The number of lymph nodes with metastatic disease portends for a poorer prognosis in women with stage IIIC-IV endometrioid uterine cancer. (2006) (0)
32/#1068 Trends in the incidence of ovarian germ cell cancers in us Asians and native Chinese (2022) (0)
The impact of surgeon learning curve and hospital volume on the survival of stage IB cervical cancer patients after minimally invasive surgery (2019) (0)
The risk of nodal metastasis and survival of various cell types of uterine cancer: A study of 16,640 patients (2008) (0)
The impact of age, race, and HPV status on the increasing incidence of cervical adenocarcinoma in U.S. women (2021) (0)
TH-C-17A-09: Direct Visualization and Monitoring of Medical Radiation Beams in Air. (2014) (0)
The impact of obesity and physical activity on inflammation and cancer mortality in women (2019) (0)
Factors associated with differences in survival of immigrants vs. U.S. born asians with uterine cancer (2013) (0)
On the Way for Patients with Prostate Cancer to the Best Use of PSMA (2022) (0)
The lack of benefit of chemotherapy for stage I uterine leiomyosarcoma patients: A retrospective analysis of 890 patients (2019) (0)
Impact of a robotic simulation program on resident surgical performance (2015) (0)
Progress in record numbers of approved therapies for gynecologic cancers: The lack of upfront approval for newly diagnosed cases. (2018) (0)
The role of lymphadenectomy and radiation therapy for malignant mixed Müllerian uterine cancers (2015) (0)
Radiation therapy for recurrent clear cell ovarian carcinoma (2013) (0)
Poster Viewing PresentationObesity and Risk of Biochemical Failure for Patients Receiving Salvage Radiotherapy after Prostatectomy (2008) (0)
Response to Dr. Oleson's comments (1991) (0)
The association of marital status, socioeconomic status, and race on the survival of ovarian cancer patients. (2019) (0)
EP020/#947 The increase in incidence of breast cancers in Asians in the United States and the Republic of China: who is most at risk? (2022) (0)
Predictive model for cancer drug approval – An analysis of FDA drug submissions over the last decade (2012) (0)
The Economic Impact of Surgical Care for Morbidly Obese Endometrial Cancer Patients: A Nationwide Study (2016) (0)
Decreasing incidence of cervical cancer in United States and Taiwan: Have we left anyone behind? (2020) (0)
The significance of the ratio of metastatic to examined lymph nodes in endometrioid uterine cancer. (2006) (0)
Kevin Analysis A Cost-Effectiveness − − Bevacizumab in Treatment of High-Risk Ovarian Cancer (2014) (0)
Comparison of solid tumor mutations under the targeted agent and profiling utilization registry (TAPUR) study: how do gynecologic cancers compare with others? (2021) (0)
Indications for the clinical use of deep local and regional hyperthermia in conjunction with radiation therapy. (1989) (0)
Comparison of the new and old FIGO staging systems for vulvar carcinoma: A study of 4842 patients (2011) (0)
Immune signatures predictive of optimal cytoreduction in ovarian cancer (2012) (0)
Location versus extent of nodal metastasis in node-positive uterine cancer: Which is more prognostic? (2011) (0)
The influence of age, race, and histology on the expression of preoperative CA-125 in stage I epithelial ovarian cancer patients (2021) (0)
The increasing incidence of cancer in younger women: What preventative strategy is best? (397) (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daniel Stuart Kapp?

Daniel Stuart Kapp is affiliated with the following schools:

Stanford University